Home / Solutions / Lead Discovery

AI-Guided Lead Discovery for Small-Molecule Drug Discovery

Synfini turns hits into validated lead molecules by designing, making, testing, and analyzing compounds in one place, so each round learns from the last.

Tell us about your target and where your hits stand.

What Is Lead Identification in Drug Discovery?

Lead identification is the stage of the drug discovery process where researchers turn hits into lead molecules: compounds with confirmed activity against a target protein and early structure activity relationships.

It decides which series reach the later stages of drug development.

STAGE 1Hit identificationScreening finds compounds of interest.STAGE 2Hit to leadConfirmation and first modifications.STAGE 3Lead identificationA series meets your lead criteria.STAGE 4Lead optimizationRefine potency, specificity, and toxicity.Synfinilead discovery

From Hit Identification to Lead Optimization

Where Lead Discovery Loses Time

High throughput screening (HTS) tests many compounds quickly, but most hits fall away on confirmation. AI design has the opposite problem: it proposes thousands of potential leads that often cannot be made.

Either way, progress slows when design, synthesis, and testing sit with different teams and information waits on each handoff.

How Synfini Finds Lead Molecules

AI design, route planning, and automated synthesis work in combination, so every compound we score is one we can make.

DesignSynDesign

Models built for your target

Score potential leads for potency, selectivity, and ADMET. Scaffold hopping opens new chemical space.

MakeSynRoute + SynBuild

Routes before designs

Every design gets a practical route. Parallel library synthesis explores each core.

TestYour assays

Hits confirmed

Compounds run in your assays, and results return as structured data.

AnalyzeSynPlan + SynDB

SAR every round

Structure activity relationships retrain the models before the next design round.

What You Bring and What We Run

We are happy to start from HTS hits, fragments, published articles, or only a validated target.

You bring

  • A validated target protein
  • Any existing hits and data
  • Your assays and lead criteria

Synfini runs

  • Target models and analog design
  • Route planning and automated synthesis
  • SAR analysis and model retraining

Step 1A conversation about your target and hits

Step 2A plan built around your lead criteria

Step 3DMTA cycles until a series is ready for lead optimization

A Worked Example with Transcripta Bio

In a collaboration announced on October 7, 2026, Transcripta Bio and Synfini identified a lead candidate against a key driver of Huntington’s disease progression in a matter of weeks.

Transcripta brought the target rationale and ran the confirmatory assays. Synfini built the predictive models, ran multiparameter optimization, and synthesized the compounds.

This is a lead-stage result. Lead-stage potency does not predict downstream success.

~40compounds synthesized in the first cycle
3novel chemical series
1design-make-test-analyze cycle

AI-Guided Lead Discovery vs. High Throughput Screening

The two methods often work together. The difference is how the next compounds are chosen.

 High throughput screeningSynfini
Starting pointA large compound libraryYour target, plus any hits
Next round guided byHit lists and follow-up screensSAR data retraining the models
What you getHits that need confirmationLeads with SAR and a synthesis route

Who This Is For

Biotech teams and research institutes that need medicinal chemistry without building chemistry resources in-house.

Hits, no chemistry team

You need a partner to design and make compounds around your hits.

A target, no hits yet

You want promising candidates without a large screening campaign.

A lead decision ahead

You need supporting SAR data to choose which series moves forward.

Frequently Asked Questions

Lead discovery is finding lead molecules: compounds with confirmed activity against a target and properties worth optimizing. It covers hit identification, hit to lead, and lead identification.

Hit identification finds compounds with any activity of interest, usually through screening. Lead identification determines which hits, after modifications, show the potency and specificity required to progress.

Hits are confirmed, analogs are made, and structure activity relationships are evaluated. The aim is a few validated leads.

HTS screens libraries of compounds against target proteins to find starting hits. Synfini can begin from HTS hits, or design starting points when no screening data exists.

Reproducible potency, a clear SAR trend, acceptable early toxicity signals, and a synthesis route that can ensure a steady supply of analogs.

When a series meets the agreed lead criteria, it moves to closed-loop lead optimization toward drug candidates.

Find Leads for Your Target

Learn how Synfini can move your program from hits to a validated lead series. A member of our team will reply within 1 business day.

Prefer email? info@synfini.com